Transient transfection with a miR-708 mimic or with a glucocorticoid agonist not only resulted in decreased IKKβ expression, but it also reduced NF-κB activation and signaling in MCF-7 and MDA-MB-231 breast cancer cells [138]. This evidence concerns the gene NFKB1 and breast carcinoma.